Direxion Daily Healthcare Bull 3X Shares (CURE) Performance
CURE total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +39.0% since Dec 31, 2025
- 1 year
- +62.9% total return
- 5 years
- +6.6% a year
- 10 years
- +19.2% a year
- Since first price
- +26.0% a year since 2011
CURE trailing returns vs SPY, QQQ, AGG
| Period | CURE total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | +17.8% | +17.8% | −1.0% | −5.0% | +0.9% |
| 3 months | +32.6% | +32.3% | +3.2% | +1.9% | −0.4% |
| 6 months | +71.3% | +70.2% | +7.8% | +8.4% | −1.5% |
| YTD | +39.0% | +37.7% | +12.3% | +15.1% | −1.0% |
| 1 year | +62.9% | +60.9% | +14.4% | +15.9% | −1.1% |
| 3 years | +88.7%+23.6%/yr | +81.6% | +87.4%+23.3%/yr | +101.4%+26.3%/yr | +16.6%+5.2%/yr |
| 5 years | +37.7%+6.6%/yr | +29.8% | +79.3%+12.4%/yr | +94.0%+14.2%/yr | −0.8%−0.2%/yr |
| 10 years | +478.0%+19.2%/yr | +435.2% | +315.9%+15.3%/yr | +538.9%+20.4%/yr | +14.0%+1.3%/yr |
| 15 years | +4,300.0%+28.7%/yr | +3,824.4% | +696.0%+14.8%/yr | +1,299.3%+19.2%/yr | +32.2%+1.9%/yr |
| Since inceptionJun 15, 2011 | +3,361.4%+26.0%/yr | +2,987.3% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: CURE vs SPY
From Jun 15, 2011: CURE grew to $346,142, SPY to $78,480.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
CURE returns by calendar year
10 of 14 full years positive. Best 2013 (+164.7%), worst 2022 (−20.5%). 2026 is year to date.
CURE annual returns table
| Year | CURE | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +39.0% | −31.1% | +12.3% | +15.1% | −1.0% |
| 2025 | +22.5% | −40.9% | +17.7% | +20.8% | +7.2% |
| 2024 | −8.5% | −37.3% | +24.9% | +25.6% | +1.3% |
| 2023 | −9.4% | −32.1% | +26.2% | +54.9% | +5.7% |
| 2022 | −20.5% | −43.0% | −18.2% | −32.6% | −13.0% |
| 2021 | +88.3% | −22.9% | +28.7% | +27.4% | −1.8% |
| 2020 | +5.0% | −69.2% | +18.3% | +48.6% | +7.5% |
| 2019 | +55.7% | −22.0% | +31.2% | +39.0% | +8.5% |
| 2018 | +2.8% | −42.3% | −4.6% | −0.1% | +0.1% |
| 2017 | +69.3% | −11.3% | +21.7% | +32.7% | +3.6% |
| 2016 | −17.5% | −34.2% | +12.0% | +7.1% | +2.4% |
| 2015 | +7.4% | −44.3% | +1.2% | +9.4% | +0.5% |
| 2014 | +80.0% | −22.6% | +13.5% | +19.2% | +6.0% |
| 2013 | +164.7% | −15.5% | +32.3% | +36.6% | −2.0% |
| 2012 | +50.8% | −19.3% | +16.0% | +18.1% | +3.8% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
CURE largest drawdowns
Now 3.4% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Jan 22, 2020 | −69.2% | Mar 23, 2020 | Jan 6, 2021 | 2 months | 11 months |
| Apr 8, 2022 | −52.2% | Aug 7, 2025 | Aug 19, 2026 | 3.3 years | 4.4 years |
| Jul 20, 2015 | −48.5% | Feb 11, 2016 | Jun 22, 2017 | 7 months | 1.9 years |
| Jul 1, 2011 | −44.4% | Oct 4, 2011 | Mar 15, 2012 | 3 months | 8 months |
| Oct 1, 2018 | −42.3% | Dec 24, 2018 | Nov 27, 2019 | 3 months | 1.2 years |
| Jan 26, 2018 | −36.3% | Apr 2, 2018 | Sep 13, 2018 | 2 months | 8 months |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
CURE risk statistics
| Statistic | 3 years | 5 years | 10 years | Since 2011 |
|---|---|---|---|---|
| Annualized return | +15.0% | +5.0% | +15.9% | +24.4% |
| Volatility (annualized) | 42.5% | 44.5% | 44.4% | 41.9% |
| Sharpe ratio | 0.44 | 0.25 | 0.50 | 0.70 |
| Sortino ratio | 0.66 | 0.38 | 0.80 | 1.14 |
| Best month | +28.6% | +29.1% | +37.6% | +37.6% |
| Worst month | −23.7% | −23.7% | −25.7% | −25.7% |
| Best 12 months | +71.6% | +71.6% | +122.3% | +164.7% |
| Worst 12 months | −43.3% | −43.3% | −43.3% | −43.3% |
| Positive months | 58% | 53% | 58% | 60% |
| Beta vs S&P 500 | 1.22 | 1.63 | 2.04 | — |
| Correlation with S&P 500 | 0.36 | 0.57 | 0.71 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
CURE rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 173 | −43.3% | +24.4% | +164.7% | 73% |
| 3-year (a year) | 149 | −13.4% | +18.9% | +103.3% | 91% |
| 5-year (a year) | 125 | +0.2% | +19.6% | +56.2% | 100% |
| 10-year (a year) | 65 | +5.8% | +19.4% | +42.3% | 100% |
Every holding period starting at a month-end since 2011. Returns for 3 years and longer are annualized.
CURE performance overview
Direxion Daily Healthcare Bull 3X Shares (CURE) returned +62.9% over the past year and +19.2% a year over ten years, with distributions reinvested. Since its first recorded price in 2011 it has returned +26.0% a year, turning $10,000 into about $346,142. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −69.2%, from Jan 22, 2020 to Mar 23, 2020, and it took 9 months to get back to the old high. CURE finished 10 of its 14 full calendar years with a gain; the best year was 2013 (+164.7%) and the worst 2022 (−20.5%). Volatility has been 41.9% a year.
Related: CURE chart, CURE dividends. See the CURE overview for the latest quote and fund facts.
CURE performance FAQ
What is the CURE return over the past year?
CURE returned +62.9% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 60.9%.
What is the average annual return of CURE?
CURE has returned +6.6% a year over 5 years, +19.2% a year over 10 years, +26.0% a year since June 15, 2011 (total return, distributions reinvested).
How much would $10,000 invested in CURE be worth?
$10,000 invested in CURE at its first recorded close on June 15, 2011 would be worth about $346,142 on October 23, 2026 with distributions reinvested.
What was the worst year for CURE?
The worst calendar year was 2022, with a total return of −20.5%. The best was 2013 at +164.7%.
What is the biggest drawdown of CURE?
The largest peak-to-trough decline was −69.2% between January 22, 2020 and March 23, 2020. It recovered to the old high on January 6, 2021, 9 months after the bottom.
How volatile is CURE?
Over the past 3 years CURE had an annualized volatility of 42.5% and a Sharpe ratio of 0.44 (excess return over 1–3 month T-bills per unit of risk).